Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v1-EN
Language French English
Date Updated 2018-01-09 2017-04-28
Drug Identification Number 02382636 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10 HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10
Common or Proper name HYDROMORPHONE HYDROMORPHONE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1x50mL 1x50mL
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Other (Please describe in comments) Delay in shipping of the drug.
Anticipated start date 2017-05-01
Actual start date 2017-05-24
Estimated end date 2017-06-26
Actual end date 2017-12-29
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Please note that another generic Hydromorphone HP is available on the market, as per Health Canada Drug Database, accessed on April 28 2017.
Health Canada comments